选择性色素再吸收抑制剂可能会增加植入物失败
Michael S Block1, Don Mercante2
1Clinical Professor, Department of Oral and Maxillofacial Surgery, LSU School of Dentistry, Private Practice, Metairie, LA.
概括
在牙植入手术期间服用选择性血清素再吸收抑制剂 (SSRI) 的患者在一年内出现植入失败的风险显著增加. 这突显了接受SSRI药物治疗的患者进行牙科植入程序的潜在并发症.
科学领域:
- 牙科植入物学 牙科植入物学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 是常见的处方药.
- 存在SSRI使用和牙植入物失败之间的潜在关联.
研究的目的:
- 为了确定SSRI暴露和牙植入物失败之间的关联.
- 在使用SSRI的患者中量化植入物失效的风险.
主要方法:
- 追溯队列研究的设计.
- 包括在2007年12月至2020年2月期间接受牙科植入物的患者.
- 作为预测变量,分析了植入物放置时的SSRI暴露.
主要成果:
- 暴露于SSRI与1年内植入物失败的风险增加2.8倍相关 (相对风险=2.8;95% CI,1.8-4.4).
- 在SSRI使用者中,植入器失效率为18.6%,非使用者为6.7%.
- 吸烟,糖尿病,骨质疏松症和虚弱等并发症也与植入物失败有关.
结论:
- 在牙科植入物手术时使用SSRI可能会增加植入物失败的风险.
- 在评估植入物失败风险时,临床医生应考虑使用SSRI.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
271
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
271
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Drugs Affecting Neurotransmitter Release or Uptake
917
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
917
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
202
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
202


